Latest Feature Article
Illuminating Rare Disease
Bringing to light the challenges and hopes for the rare disease community
Feature Articles
Shriners Hospitals Launches Ambitious Sequencing Initiative
Genomic luminaries Drs. Marc Lalande and Kamran Shazand establish the Genomics Institute
Q&A: Jenn Foley, Illumina’s Most Prolific Female Inventor
Talking diagnostic odysseys, perseverance, and overcoming failure
Leaders in COVID Surveillance: Utah Public Health Laboratory
Inside a model public health lab paving the way with genomic sequencing
Video: Driving the Global Development of Cancer Therapy Selection
Studies from Japan and Belgium seek to advance precision medicine in oncology
Press Releases
In the News
| Date | Publication | Title |
|---|---|---|
| Mar 5, 2021 | GenomeWeb | Illumina Receives Medical Device Registration in Russia for NextSeq 550 Dx Sequencer, Reagents |
| Mar 5, 2021 | ClinicalOMICs | Illumina Granted Registration in Russia for Clinical NGS Platform, Reagents |
| Mar 4, 2021 | Tele Z (Switzerland) | Wie Entstehen Coronavirus-Mutationen? |
| Feb 26, 2021 | Investor's Business Daily | Coronavirus Mutations: Why The Battle Against Covid Is Just Beginning |
| Feb 25, 2021 | BioPharma Reporter | German program using whole genome sequencing to diagnose rare diseases and cancer risk |
Additional Resources
Investor Information
Careers at Illumina
At Illumina, we push boundaries. We think beyond the conventional. We dream big. With the energy of so many bright and accomplished people, the opportunities are endless.
Search for JobsPress Contacts
If you are a member of the media:
- Email pr@illumina.com
- Tel. 858.882.6822
If you are not a member of the media, please visit Contact Us.